Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P. J. Lolkema, Astrid A. M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017; 72: 411-23. Beyond the Survival Rate, Health-related Quality of Life is Important

Maud Rijnders; Ronald de Wit; Joost Boormans; Martijn Lolkema; Astrid van der Veldt

doi:10.1016/j.eururo.2017.10.015

Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P. J. Lolkema, Astrid A. M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017; 72: 411-23. Beyond the Survival Rate, Health-related Quality of Life is Important

Maud Rijnders, Ronald de Wit, Joost Boormans, Martijn Lolkema, Astrid van der Veldt

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	E67-E68
Journal	European Urology
Volume	73
Issue number	3
DOIs	https://doi.org/10.1016/j.eururo.2017.10.015
Publication status	Published - 2018

Research programs

EMC MM-03-49-01
EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2017.10.015

http://hdl.handle.net/1765/102801

Cite this

Rijnders, M., de Wit, R., Boormans, J., Lolkema, M., & van der Veldt, A. (2018). Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P. J. Lolkema, Astrid A. M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017; 72: 411-23. Beyond the Survival Rate, Health-related Quality of Life is Important. European Urology, 73(3), E67-E68. https://doi.org/10.1016/j.eururo.2017.10.015

Rijnders, Maud ; de Wit, Ronald ; Boormans, Joost et al. / Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P. J. Lolkema, Astrid A. M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017; 72: 411-23. Beyond the Survival Rate, Health-related Quality of Life is Important. In: European Urology. 2018 ; Vol. 73, No. 3. pp. E67-E68.

@article{2f527877af3d4360a224db6e429de40c,

title = "Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P. J. Lolkema, Astrid A. M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017; 72: 411-23. Beyond the Survival Rate, Health-related Quality of Life is Important",

author = "Maud Rijnders and {de Wit}, Ronald and Joost Boormans and Martijn Lolkema and {van der Veldt}, Astrid",

year = "2018",

doi = "10.1016/j.eururo.2017.10.015",

language = "Undefined/Unknown",

volume = "73",

pages = "E67--E68",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "3",

}

Rijnders, M , de Wit, R , Boormans, J, Lolkema, M & van der Veldt, A 2018, 'Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P. J. Lolkema, Astrid A. M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017; 72: 411-23. Beyond the Survival Rate, Health-related Quality of Life is Important', European Urology, vol. 73, no. 3, pp. E67-E68. https://doi.org/10.1016/j.eururo.2017.10.015

Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P. J. Lolkema, Astrid A. M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017; 72: 411-23. Beyond the Survival Rate, Health-related Quality of Life is Important. / Rijnders, Maud ; de Wit, Ronald ; Boormans, Joost et al.
In: European Urology, Vol. 73, No. 3, 2018, p. E67-E68.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P. J. Lolkema, Astrid A. M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017; 72: 411-23. Beyond the Survival Rate, Health-related Quality of Life is Important

AU - Rijnders, Maud

AU - de Wit, Ronald

AU - Boormans, Joost

AU - Lolkema, Martijn

AU - van der Veldt, Astrid

PY - 2018

Y1 - 2018

U2 - 10.1016/j.eururo.2017.10.015

DO - 10.1016/j.eururo.2017.10.015

M3 - Article

C2 - 29100815

SN - 0302-2838

VL - 73

SP - E67-E68

JO - European Urology

JF - European Urology

IS - 3

ER -

Rijnders M , de Wit R , Boormans J, Lolkema M, van der Veldt A. Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P. J. Lolkema, Astrid A. M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017; 72: 411-23. Beyond the Survival Rate, Health-related Quality of Life is Important. European Urology. 2018;73(3):E67-E68. doi: 10.1016/j.eururo.2017.10.015